Shamonda virus
Shamonda virus is transmitted by biting midges and affects cattle and other animal species, including sheep, goats, horses and alpacas. Infection can cause fever, reduced milk production and reproductive disorders, including abortions and foetal malformations.
Last updated: 21 October 2026
What is Shamonda virus?
Shamonda virus belongs to the Simbu group of viruses, which also includes Schmallenberg virus. First isolated in cattle in Nigeria in 1965, it has since been identified in parts of Africa, Asia and Europe.
The virus is understood to spread through bites from Culicoides midges. Recent reports mainly concern cattle, although cases have also been reported in sheep, goats, horses and alpacas.
Reported signs in animals include fever, diarrhoea, reduced milk production and reproductive disorders, including abortions and foetal malformations. Neurological signs have also been reported less commonly. Laboratory testing is needed to confirm infection, as these signs can resemble those of other diseases.
What is WOAH doing?
WOAH is working with its Reference Centres and expert networks to assess available evidence and monitor developments. It stands ready to support Members with diagnostic expertise, scientific advice and technical assistance.
WOAH encourages Members to voluntarily report occurrences of Shamonda virus infection in their territories to help improve understanding of its distribution and impact on animal health.
Questions and answers about Infection with Shamonda virus in cattle and other animal species in Europe
Note: Information on the Shamonda virus variants currently detected in Europe is still evolving. Several aspects of the disease remain incompletely characterised, including its epidemiology, full geographic distribution, pathogenicity, long-term impact and zoonotic potential. The precise characterisation and nomenclature for these variants are also still being defined. For the purposes of this FAQ, when referring to the specific variants circulating in Europe it will be referred to as the European variants of Shamonda virus. This FAQ reflects the epidemiological observations and research done to date and will be updated when additional information becomes available.
Shamonda virus is a vector-borne virus belonging to the genus Orthobunyavirus in the family Peribunyaviridae. It is part of the Simbu serogroup, which also includes Schmallenberg virus. Transmitted by midges, Shamonda virus was first isolated from cattle in Nigeria in 1965. From the early 2000s onwards, the virus has been identified in other regions of Africa and Asia, before the recent identification in Europe.
The outbreaks in Europe in 2026 have been shown to be caused by two different variants of the virus, designated as Shamonda virus Europe 1 (SHAV-EU1) and Shamonda virus Europe 2 (SHAV-EU2).
Reports indicate the emergence and spread of a Shamonda-like virus in several countries in Europe. The level of detail and quality of evidence is variable and is dependent on individual country’s capacity for surveillance, laboratory diagnosis, and publication of information.
The long-term impact and significance of the disease in Europe cannot currently be determined. Outbreaks caused by Simbu group viruses (which includes Shamonda and Shamonda-like viruses) tend to occur in cycles following the seasonal patterns of midges. However, the behaviour of the European variants of Shamonda, and specifically their behaviour in immunologically naive cattle populations, may differ from that of Shamonda virus in endemic countries.
According to recent reports, the virus is most commonly reported in cattle, but there have also been cases in horses, alpaca, sheep and goats.
Shamonda virus has historically not been recognised as a cause of disease in humans. However, the first ever reported human infection with Shamonda virus was reported in October 2026 in France in a patient with a severely compromised immune system. Further investigations are required to understand if the virus caused or contributed to the patient’s death, how they became infected, and the public health implication of this exceptional finding. WOAH is working closely with The World Health Organisation (WHO), the French Authorities and our scientific network to better understand and monitor any potential human health risk.
Transmission is currently understood to occur through bites from Culicoides midges. There is currently no evidence of animal-to-animal transmission through direct contact. Vertical transmission has been reported. Further evidence is needed to better understand all routes of transmission.
Clinical sings include:
Fever
Diarrhoea
Reduced milk production
Abortions
Reproductive disorder such as abortions and foetal malformations
Neurologic disorders (reported less commonly and demonstrated in some horses)
Yes, Shamonda virus has been associated with congenital malformations and reproductive disorders. There have been reports of abortions and severe foetal malformations in some affected animals in the 2026 outbreaks in Europe, however, the European Shamonda virus variants’ full teratogenic effects currently remain unknown.
Due to unspecific clinical signs, laboratory diagnosis is necessary. It includes:
– Pan-Simbu PCR
– Specific RT-PCR targeting the S segment
– Sequencing and multi-segment screening of the M and L segments
– Commercial real-time RT-PCR kits available in Europe
– Serum neutralization tests for antibody detection and differentiation from other Simbu serogroup viruses
– Suitable sample types include:
– EDTA blood
– Serum from animals in the acute phase of infection
– Brain tissue from aborted foetuses
– Spleen tissue from aborted foetuses
There are currently no commercially available vaccines against Shamonda virus.
According to the Friedrich-Loeffler-Institut (FLI), there appears to be little cross-protection from existing immunity to Schmallenberg virus. The potential impact of this finding is unknown.
Control of potential Culicoides vectors during the vector-active season may decrease the transmission of virus. Risk management strategies may include:
– Physical barriers such as fine mesh screens and double-door entry-exit systems
– Reducing or eliminating vector breeding sites
– Vector surveillance and control around buildings
– Use of insect repellents during animal transport
– Transporting animals during periods of low vector activity
Further details preventing Culicoides attacks can be found in Chapter 8.3 (Infection with Bluetongue virus), Article.8.3.13 of the WOAH Terrestrial Animal Health Code.
No, infection with Shamonda virus is not a WOAH listed disease and it is not recognised as an emerging disease under Article 1.1.4 of the Terrestrial Animal Health Code. However, WOAH encourages affected Members to voluntary report the information under Article 1.1.5 of the Terrestrial Animal Health Code. Such information supports transparency and helps improve our Members’ understanding of the epidemiology, distribution and impact of the virus. Further details on how to report under Article 1.1.5 is available on Reporting under Article 1.1.5 : WAHIS Support
– Strengthen monitoring systems where national risk assessment indicates likelihood of virus introduction and circulation.
– Include Shamonda virus infection in the differential diagnosis of congenital malformations, stillbirths and reproductive disorders in susceptible species, where relevant and investigate suspected cases potentially associated with Shamonda virus infection.
– Collaborate with WOAH Reference Centres and partner laboratories to support diagnosis, characterisation and risk assessment activities and continue to inform WOAH of important animal health events.
WOAH recalls that Members should avoid implementing unjustified trade restrictions. Any sanitary measures potentially affecting international trade should be science-based, proportionate to the risk and supported by an import risk analysis conducted according to the Terrestrial Animal Health Code Chapter 2.1.